- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03551977
The Norwegian "iCanCope With Pain" App
Cultural Adaptation and Evaluation of the "iCanCope With Pain" App Among Norwegian Adolescents Living With Pain
Background: Research evidence shows that prevalence of pain in adolescents is increasing and is therefore recognized as a growing health problem. Psychological interventions delivered remotely through the internet may reduce intensity or severity of pain among children and adolescents with chronic pain. The iCanCope with Pain program is an existing web- and mobile-based self-management program, which is developed as a multi-center study funded by the Canadian Institutes of Health Research and is based on identified health care needs and current best practices for pain self-management.
Objectives: The primary objectives are to describe the translation and cultural adaptation of the Norwegian version of the iCanCope with Pain mobile application and evaluate the effect in an upcoming randomized controlled trail with adolescents with chronic pain.
Study sample: 16-19-year-old adolescents with self-declared persistent and/or chronic pain. Recruited from high schools in Southern Norway.
Theoretical framework: Cognitive behavioral therapy (CBT) is explained by an integration of behavioral and cognitive theories of human behavior and psychopathology and is often the preferred treatment of choice for adolescents with different health disorders. The theoretical framework of CBT is integrated in the iCanCope with Pain app in terms of five components. The intervention group will receive the app with all five components: (I) symptom trackers for pain, sleep, mood, physical, and social function; (II) goal setting to improve pain and function; (III) coping toolbox of pain self-management strategies; (IV) social support; (V) age-appropriate pain education. The control group will receive the app with only the first self-registration component (I) symptom trackers for pain, sleep, mood, physical, and social function.
Methods: Both qualitative and quantitative data will be gathered for evaluating the Norwegian version of the iCanCope with Pain app. Usability testing are assessed in both laboratory settings and in field using observation, interviews and questionnaires, which provide necessary information for an upcoming randomized controlled trail (RCT). Outcomes will in the RCT be measured at baseline (mid-April) and after an 8 weeks intervention (mid-June).
The study is part of a PhD project.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
-
Kristiansand, Noruega, 4633
- Erik Grasaas
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- 16-19-year-old adolescents
- with persistent and/or chronic pain, weekly suffered and lasting 3 months or more based on subjective reporting
- be able to read and understand Norwegian
- have their own smartphone.
Exclusion Criteria:
- Adolescents with cognitive disability or diseases, because of the risk of not correctly understanding the iCanCope with Pain program via self-report, goal setting and/or library reading.
- Adolescents that have participated in the usability testing of the Norwegian iCanCope with Pain app
- Adolescents with diagnoses from a pathological or medical origin (e.g hematology/oncology patients) will also be excluded because the program was not specifically designed for these pain groups.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
---|---|
Experimental: Intervention group
The intervention group will receive the iCanCope with Pain app with all five components: (I) symptom trackers for pain, sleep, mood, physical, and social function; (II) goal setting to improve pain and function; (III) coping toolbox of pain self-management strategies; (IV) social support; (V) age-appropriate pain education
|
The participants are free to use the Norwegian iCanCope with Pain app as much as they want during the 8 week intervention period.
The only support available is technical support.
|
Comparador Ativo: Control group
The control group will receive the iCanCope with Pain control app with only the first self-registration component (I) symptom trackers for pain, sleep, mood, physical, and social function.
|
The participants are free to use the Norwegian iCanCope with Pain control app as much as they want during the 8 week intervention period.
The only support available is technical support.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Attrition rate
Prazo: Baseline and 8-weeks
|
Change in participants completed the post-questionnaire divided by the number of participants at baseline.
|
Baseline and 8-weeks
|
App engagement
Prazo: Baseline to 8 weeks.
|
Completion of daily symptom check-ins was used as a proxy for app engagement.
|
Baseline to 8 weeks.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
---|---|---|
Physical activity
Prazo: Baseline and 8 weeks (post-intervention)
|
Change in total score of the International Physical Activity Questionnaire (IPAQ).
Higher values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Coping
Prazo: Baseline and 8 weeks (post-intervention)
|
Change in total score of the General Self-Efficacy Questionnaire Short Version (GSEQ).
Higher values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Social participation
Prazo: Baseline and 8 weeks (post-intervention)
|
Change in total score of school absence (General Information Questionnaire).
Lower values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Over-The-Counter (OTC) analgesics
Prazo: Baseline and 8 weeks (post-intervention)
|
Change in total score of OTC analgesics consumption (General Information Questionnaire).
Lower values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Perceived social support from friends
Prazo: Baseline and 8 weeks (post-intervention)
|
Change in total score of the Perceived Social Support from friends Questionnaire (PSS).
Higher values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Pain self-efficacy questionnaire
Prazo: Baseline and 8 weeks (post-intervention)
|
Change in total score of the Pain Self-Efficacy Questionnaire (PSEQ).
Higher values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Anxiety and depression
Prazo: Baseline and 8 weeks (post-intervention)
|
Change in total score of the Hospital Anxiety and Depression Scale Questionnaire (HADS).
Lower values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Global impression of change
Prazo: After 8 weeks (post-intervention)
|
Change in Patients' Global Impression of Change Scale (PGIC) from 1-7.
Higher values at post-intervention represent a better outcome.
|
After 8 weeks (post-intervention)
|
Health-related quality of life (HRQOL)
Prazo: Baseline and 8 weeks (post-intervention)
|
Change in total score of the Kidscreen 52 Questionnaire.
Higher values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Pain experience
Prazo: Baseline and 8 weeks (post-intervention)
|
Change in total score of the Lubeck Pain Questionnaire (LPQ).
Lower values at post-intervention represent a better outcome.
|
Baseline and 8 weeks (post-intervention)
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Kristin Haraldstad, PhD, UiA
Publicações e links úteis
Publicações Gerais
- Grasaas E, Helseth S, Fegran L, Stinson J, Smastuen M, Lalloo C, Haraldstad K. App-based intervention among adolescents with persistent pain: a pilot feasibility randomized controlled trial. Pilot Feasibility Stud. 2022 Jul 27;8(1):158. doi: 10.1186/s40814-022-01113-0.
- Grasaas E, Helseth S, Fegran L, Stinson J, Smastuen M, Haraldstad K. Health-related quality of life in adolescents with persistent pain and the mediating role of self-efficacy: a cross-sectional study. Health Qual Life Outcomes. 2020 Jan 30;18(1):19. doi: 10.1186/s12955-020-1273-z.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Outros números de identificação do estudo
- 1310 63221
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em iCanCope with Pain
-
The Hong Kong Polytechnic UniversityConcluídoDispositivo ineficazHong Kong
-
Tilburg UniversityRecrutamentoDepressão pós-parto | Estresse dos pais | Ansiedade pós partoHolanda
-
Hopital FochRescindido
-
Mayo ClinicConcluídoDoença agudaEstados Unidos
-
Shaare Zedek Medical CenterNanovibronixDesconhecido
-
Pfizer's Upjohn has merged with Mylan to form Viatris...ConcluídoNeuralgia | Dor neuropática | Dor no nervo
-
Duke UniversityConcluídoArtrite do Joelho | Artrite do quadrilEstados Unidos
-
Teesside UniversityConnect Health LtdConcluído
-
Children's Hospital of PhiladelphiaConcluído
-
Ankara Yildirim Beyazıt UniversityRecrutamentoDor musculoesquelética | QuestionárioPeru